This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
Science Hub

Welcome to Novo Nordisk Science Hub

The information on this website is intended for healthcare professionals only and is provided solely for the purpose of scientific exchange. By accessing this website you accept this legal disclaimer and you expressly confirm your status as a healthcare professional.

 

This website is not country specific and may therefore contain information that is not applicable to your country. The website is not intended to provide medical advice and/or treatment guidance. Therefore, before prescribing any product, always refer to information approved by regulatory authorities in your country such as the prescribing information and/or the Summary of Product Characteristics. Novo Nordisk accepts no liability for the accuracy, completeness or use of information on this website, and disclaims any liability to update the information contained on this website.

Are you a healthcare professional?

Speaker - Peter Libby
Peter
Libby
Brigham and Women’s Hospital, Boston, USA

Peter Libby is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, USA and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. He directed Cardiovascular Medicine at Brigham and Women’s Hospital from 1998 to 2014 and is the president of the International Atherosclerosis Society.

 

His current research focus is the role of inflammation in vascular diseases such as atherosclerosis. Prof. Libby’s research has been published extensively in prominent journals and he has received numerous research awards. He served as a member of the CANTOS steering committee and is the editor-in-chief of the current 12th edition of Braunwald’s Heart Disease.

 

Prof. Libby has served as the president of the Association of University Cardiologists, and the chairman of several research committees and member of executive committees of the American Heart Association. Prof. Libby presided over the ACC’s Research Peer Review Committee for two terms. He has frequently consulted for the US National Heart, Lung, and Blood Institute (NHLBI), including membership on the Board of Scientific Councillors. He directed the DW Reynolds Cardiovascular Clinical Research Center and two cycles of Leducq Foundation Awards and has received continuous funding from the NHLBI for several decades.